Pluri (NASDAQ:PLUR) Releases Earnings Results

Pluri (NASDAQ:PLUR) posted its quarterly earnings data on Tuesday. The company reported ($0.53) EPS for the quarter, Zacks reports. Pluri had a negative return on equity of 917.18% and a negative net margin of 4,184.28%.

Pluri Stock Up 1.8 %

PLUR stock traded up $0.08 on Thursday, hitting $4.45. 1,086 shares of the company’s stock were exchanged, compared to its average volume of 12,347. The firm has a 50 day moving average price of $4.50 and a two-hundred day moving average price of $4.98. The company has a debt-to-equity ratio of 4.44, a quick ratio of 5.90 and a current ratio of 5.90. Pluri has a 12-month low of $4.07 and a 12-month high of $8.48. The stock has a market cap of $24.74 million, a P/E ratio of -0.74 and a beta of 1.67.

About Pluri

Pluri Inc, a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production.